Recruiting

Boosting Emotional Well-being and Happiness in Outpatients Living With Diabetes

The focus of this study is to test the efficacy of an 8-week, remotely delivered, positive-psychology-motivational interviewing (PP-MI) intervention, with additional twice weekly text messages for a total of 16 weeks (with interactive, algorithm-driven, goal-focused text messages in the final 8 weeks), compared to MI-alone, in a randomized trial of 280 individuals with type 2 diabetes and low baseline physical activity.

I'm interested View official listing
ClinicalTrials.gov IDNCT05420051
PhaseNA
Enrollment280
SponsorMassachusetts General Hospital
Age18 Years and older
SexALL
I'm interested View official listing

Conditions studied

Diabetes Mellitus, Type 2

About this study

The focus of this study is to test the efficacy of an 8-week, remotely delivered, positive-psychology-motivational interviewing (PP-MI) intervention, with additional twice weekly text messages for a total of 16 weeks (with interactive, algorithm-driven, goal-focused text messages in the final 8 weeks), compared to MI-alone, in a randomized trial of 280 individuals with type 2 diabetes and low baseline physical activity.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Diagnosis of Type 2 Diabetes * Low physical activity (\<150 minutes/week of moderate to vigorous physical activity) Exclusion Criteria: * Cognitive deficits impeding a participant's ability to provide informed consent or participate * Medical conditions likely to lead to death within 6 months. * Pre-existing coronary artery disease * Moderate-severe depression (Patient Health Questionnaire-9 \[PHQ-9\] score ≥15) * Use of non-basal insulin * Inability to participate in physical activity due to another medical condition * Inability to receive text messages * Inability to read, write, or speak in English * Current participation in another intervention or program that has been designed to promote well-being or physical activity

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-13.